(Photo: Getty Images) This week, LeDevoir spotlighted the collaborative endeavors of TheNeuro (Montreal Neurological Institute-Hospital) alongside partners such as ourselves. 👉The Neuro is the largest… Read More »Le Devoir spotlighted The Neuro and eNUVIO
Our CEO and co-founder, Hugo McGuire, recently had the opportunity to share eNUVIO’s journey and innovations on the VatorNews innovation podcast from San Francisco. Huge… Read More »Hugo McGuire, CEO and co-founder at eNUVIO, on the VatorNews innovation podcast
We’re thrilled and honored to share the exciting news that eNUVIO has been selected to join the Hypercroissance Québec cohort of 2024! This recognition underscores… Read More »eNUVIO joined the Hypercroissance Québec cohort of 2024!
This was our second time at the SLAS conference organized by the Society for Laboratory Automation and Screening and we want to take the opportunity… Read More »Thanks for visiting us at SLAS 2023!
Familial dysautonomia (FD) is a rare neurodevelopmental and neurodegenerative disorder that affects the sympathetic and sensory nervous system. In this article, the authors employ the… Read More »Publication Spotlight
Our newest addition to the OMEGAACE series is here! 🎉 We love to make your dreams come true. This time you asked us for a small… Read More »The new OMEGA-ACE-4mm is now available
🥳 We are thrilled to announce that we are now officially offering contract research services! Our goal? Making human-relevant in vitro disease models as accessible… Read More »We now offer fully customized contract research services
From June 15 to June 17 2022, we were in San Francisco for the annual meeting of the International Society for Stem Cell Research! Thank… Read More »Thanks for joining us at ISSCR 2022!
In this article, we cover the advantages of microfluidic devices over standard culture vessels, some of the shortcomings of conventional microfluidic devices, and then explain… Read More »Comparing Microfluidic Cell Culture Devices
Montreal, Canada, April 11th 2022 – eNUVIO officially announced the release of the EB-CLARIFY device, an all-in-one embryoid body (EB) formation, processing, and imaging device… Read More »eNUVIO is Launching the EB-CLARIFY Device
